E. Ann Tallant

Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2

Carlos M. Ferrario, Jewell A. Jessup, Mark C. Chappell et al. · Circulation · 2005 · 1.6K citations

Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors

Yuichiro Ishiyama, Patricia E. Gallagher, David B. Averill et al. · Hypertension · 2004 · 569 citations

Hypertension, Angiotensin Ii, Cardiovascular Disease +14

Protein activator of cyclic 3′:5′-nucleotide phosphodiesterase of bovine or rat brain also activates its adenylate cyclase

Wai Yiu Cheung, Laurence S. Bradham, Thomas J. Lynch et al. · Biochemical and Biophysical Research Communications · 1975 · 361 citations

Protein Activator, Molecular Neuroscience, Molecular Physiology +12

Phosphorylation fails to activate chloride channels from cystic fibrosis airway cells

Robert Schoumacher, R. L. Shoemaker, Dan R. Halm et al. · Nature · 1987 · 337 citations

Signal Transduction, Molecular Physiology, Cell Signaling +10

Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the<i>mas</i>receptor

E. Ann Tallant, Carlos M. Ferrario, Patricia E. Gallagher · American Journal of Physiology-Heart and Circulatory Physiology · 2005 · 315 citations

Cardiac Muscle, Heart Failure, Receptor Antagonist +17